Remove 2009 Remove Disease Remove Nurses Remove Treatment
article thumbnail

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

The Pharma Data

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e.,

article thumbnail

Comment: Drug discovery and the International Day of Action for Women’s Health

Drug Discovery World

Furthermore, insufficient availability and analysis of women-specific health data undermine advancements in disease-state understanding and limit asset discovery opportunities across medical conditions with meaningful unmet need.” 1 Clinical trials Until recently, medicines and vaccines were mainly tested on men.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The New Fungus Among Us, Candida auris

PLOS: DNA Science

. “What is different and particularly scary about Candida auris is that it can survive on skin and healthcare surfaces up to two weeks, allowing the spread from person-to-person in healthcare settings and nursing homes. The lineages comprising evolutionary trees, from people to viruses, are called phylogenies.

DNA 52
article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Non-alcoholic fatty liver disease and fructose: bad for us, better for mice. 2009 Jun;139(6):1242S-1245S. PMID: 7400482. 2011;55(1):218–20 DOI: 10.1016/j.jhep.2011.01.029.

Disease 52
article thumbnail

Neurobiology & Organismal Biology

Broad Institute

in Physics from the University of Illinois at Urbana-Champaign in 2009. Through his comprehensive investigations, he strives to advance knowledge and identify potential therapeutic interventions for stress-related psychiatric disorders and neurodegenerative diseases. in Physics from Massachusetts Institute of Technology in 2009.

article thumbnail

INVO Bioscience Forms Scientific Advisory Board with Leaders from Fertility Industry

The Pharma Data

In 2009 Tony took on the challenge of a new start up in San Antonio at RMATX that has grown to 2 IVF centers and 2 satellite centers. She speaks nationally and internationally on how cancer and autoimmune disease therapies affect reproductive health and fertility, ovarian aging, primary ovarian insufficiency and genetics.